Plaintiffs Support, Oppose Eliquis Anticoagulant MDL Sought By Defense

(November 7, 2016, 1:43 PM EST) -- WASHINGTON, D.C. — Two groups of plaintiffs on Nov. 4 said they support centralization of all federal Eliquis drug cases into a multidistrict litigation, but one group says voluntary coordination will suffice (In Re:  Eliquis [Apixaban] Products Liability Litigation, MDL Docket No. 2754, JMPDL).

On Oct. 13, Eliquis co-manufacturers Bristol-Myers Squibb Co. (BMS) and Pfizer Inc. filed a motion asking the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize 34 lawsuits from 13 federal district courts in the U.S. District Court for the Southern District of...
To view the full article, register now.